Claims for Patent: 4,677,192

Summary for Patent: 4,677,192

Title:	Process for the separation of mixtures of insulin, insulin derivatives and, where appropriate, impurities
Abstract:	A method for separating insulin or certain insulin derivatives from mixtures containing the same by chromatography of the mixture on a column filled with silica gel having a particle size between 40 and 500 microns with an eluant mixture comprising chloroform, methanol, water and triethylamine.
Inventor(s):	Obermeier; Rainer (Hattersheim am Main, DE), Teetz; Volker (Hofheim am Taunus, DE), Ludwig; Jurgen (Brachttal, DE)
Assignee:	Hoechst Aktiengesellschaft (Frankfurt am Main, DE)
Application Number:	06/804,325
Patent Claims:	1. A method for the recovery of a human insulin ester and pig insulin from a mixture containing then and resulting from an enzymic conversion of pig insulin into human insulin ester, which method comprises chromatographing said mixture on a column filled with silica gel having an average particle size between 40 and 125 microns using an eluant mixture comprising, in parts by volume, 1500-2100 parts of chloroform, 1000-1500 parts of methanol, 350-450 parts of water, 35-55 parts of triethylamine, and more than 0 and up to 15 parts of formic acid, and recovering the pig insulin and the human insulin ester from the eluate in different fractions, the enzyme remaining absorbed on the silica gel column. 2. A method for the recovery of a human insulin ester and pig insulin from a mixture containing them and resulting from an enzymic conversion of pig insulin into human insulin ester, which method comprises chromatographing said mixture on a column filled with silica gel having an average particle size between 40 and 125 microns using an eluant mixture comprising, in parts by volume, 1500-2100 parts of chloroform, 1000-1500 parts of methanol, 350-450 parts of water, 35-55 parts of triethylamine, more than 0 and up to 15 parts of formic acid, and more than 0 and up to 350 parts of a 2-(C.sub.1 -C.sub.4 -alkoxy)-ethanol, and recovering the pig insulin and the human insulin ester from the eluate in different fractions, the enzyme remaining absorbed on the silica gel column. 3. A method for the recovery of human insulin from a mixture resulting from an enzymic conversion of pig insulin into human insulin and containing pig insulin and a human insulin ester, which method comprises chromatographing said mixture on a column filled with silica gel having an average particle size between 40 and 125 microns using an eluant mixture comprising, in parts by volume, 1500-2100 parts of chloroform, 1000-1500 parts of methanol, 350-450 parts of water, 35-55 parts of triethylamine, and more than 0 and up to 15 parts of formic acid, whereby said pig insulin and human insulin ester are eluted in different fractions, subjecting said human insulin ester fraction to acid cleavage with trifluoroacetic acid, and then chromatographing the cleavage product again on a column filled with silica gel having an average particle size between 40 and 125 microns using an eluant mixture comprising, in parts by volume, 1500-2100 parts of chloroform, 1000-1500 parts of methanol, 350-450 parts of water, more than 0 and up to 15 parts of formic acid, more than 0 and up to 350 parts of a 2-(C.sub.1 -C.sub.4 -alkoxy)-ethanol, and 35-55 parts of triethylamine, whereby human insulin and unreacted ester in said cleavage product are eluted in different fractions. 4. A method for separating human insulin from a human insulin ester, which method comprises chromatographing a mixture containing said insulin and said ester on a column filled with silica gel having a particle size between 40 and 500 microns using an eluant mixture comprisng, in parts by volume, 1500-2100 parts of chloroform, 1000-1500 parts of methanol, 350-450 parts of water, more than 0 and up to 15 parts of formic acid, and 35-55 parts of triethylamine, whereby said insulin and said ester are eluted in different fractions. 5. A method as in claim 1 wherein said silica gel has a particle size between 40 and 63 microns. 6. A method as in claim 1 wherein said silica gel has a particle size between 63 and 125 microns. 7. A method as in claim 1 wherein said ester is human insulin B30-(Bu.sup.t).sub.2. 8. A method as in claim 1 wherein human insulin B30-(Bu.sup.t).sub.2 is separated from a mixture containing the same together with pig insulin and trypsin. 9. A method for the recovery of a human insulin ester and pig insulin from a mixture containing them and resulting from an enzymic conversion of pig insulin into human insulin ester, which method comprises chromatographing said mixture on a column filled with silica gel having a particle size between 40 and 500 microns using an eluant mixture comprising, in parts by volume, 1500-2100 parts of chloroform, 1000-1500 parts of methanol, 350-450 parts of water, 35-55 parts of triethylamine and more than 0 and up to 15 parts of formic acid, and at least one component selected from the group consisting of 0-1800 parts of methylene chloride, and 0-350 parts of a 2-(C.sub.1 -C.sub.4 -alkoxy)ethanol. 10. A method as in claim 4 wherein said eluant mixture additionally comprises a 2-(C.sub.1 -C.sub.4 -alkoxy)ethanol. 11. A method as in claim 4 wherein said eluant mixture additionally comprises 2-methoxyethanol.

Details for Patent 4,677,192

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	HUMULIN R U-100	insulin human	Injection	018780	October 28, 1982	4,677,192	2005-12-04
Eli Lilly And Company	HUMULIN R U-500	insulin human	Injection	018780	December 29, 2015	4,677,192	2005-12-04
Eli Lilly And Company	HUMULIN R U-100	insulin human	Injection	018780	August 06, 1998	4,677,192	2005-12-04
Eli Lilly And Company	HUMULIN R U-500	insulin human	Injection	018780	March 31, 1994	4,677,192	2005-12-04